SMALLPOX FACT SHEET
Smallpox Disease Overview
Smallpox is a serious, contagious, and sometimes fatal infectious disease. The pox part of smallpox is derived from the Latin word for “spotted” and refers to the raised bumps that appear on the face and body of an infected person.
There are two clinical forms of smallpox. Variola major is the severe and most common form of smallpox, with a more extensive rash and higher fever. There are four types of variola major smallpox: ordinary (the most frequent type, accounting for 90% or more of cases); modified (mild and occurring in previously vaccinated persons); flat; and hemorrhagic (both rare and very severe). Historically, variola major has an overall fatality rate of about 30%; however, flat and hemorrhagic smallpox usually are fatal. Variola minor is a less common presentation of smallpox, and a much less severe disease, with death rates historically of 1% or less.
Smallpox outbreaks have occurred from time to time for thousands of years, but the disease is now eradicated after a successful worldwide vaccination program. The last case of smallpox in the United States was in 1949. The last naturally occurring case in the world was in Somalia in 1977. After the disease was eliminated from the world, routine vaccination against smallpox among the general public was stopped because it was no longer necessary for prevention.
Treatment and Prevention
There is no proven treatment for smallpox disease. Prevention is achieved through vaccination. For purposes of controlling a smallpox outbreak, smallpox vaccine and antivirals can be used.
Cidofovir and Brincidofovir (CMX001)
Data is not available on the effectiveness of antiviral drugs Cidofovir and Brincidofovir in treating human cases of smallpox. However, both have proven activity against poxviruses in in vitro and animal studies.
It is unknown whether or not a person with severe smallpox infection will benefit from treatment with either antiviral, although their use may be considered in such instances. Brincidofovir may have an improved safety profile over Cidofovir. Serious renal toxicity or other adverse events have not been observed during treatment of cytomegalovirus infections with Brincidofovir as compared to treatment using Cidofovir.
Data is not available on the effectiveness of antiviral drug ST-246 in treating human cases of smallpox. Studies using a variety of animal species have shown that ST-246 is effective in treating orthopoxvirus-induced disease. Human clinical trials indicated the drug was safe and tolerable with only minor side effects.
ST-246 is currently stockpiled by the Strategic National Stockpile and is anticipated to be used in case of a smallpox emergency under Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).
Smallpox can be prevented by the smallpox vaccine. If given to a person before exposure to the virus, the vaccine can protect them. Vaccination within 3 days after exposure may prevent or greatly lessen the severity of smallpox in most people. Vaccination 4 to 7 days after exposure likely offers some protection from disease or may decrease the severity of disease. Vaccination will not protect smallpox patients who already have a rash.
Currently, the smallpox vaccine is not available to the general public. However, there is enough smallpox vaccine stockpiled to vaccinate every person in the United States in the event of a smallpox emergency.
For more details about vaccination, see Smallpox Vaccine Basics.
Where Smallpox Comes From
Smallpox is caused by the variola virus that emerged in human populations thousands of years ago. Except for laboratory stockpiles, the variola virus has been eliminated. However, in the aftermath of the events of September and October, 2001, there is heightened concern that the variola virus might be used as an agent of bioterrorism. For this reason, the U.S. government is taking precautions for dealing with a smallpox outbreak.
Generally, direct and fairly prolonged face-to-face contact is required to spread smallpox from one person to another. Smallpox also can be spread through direct contact with infected bodily fluids or contaminated objects such as bedding or clothing. Rarely, smallpox has been spread by virus carried in the air in enclosed settings such as buildings, buses, and trains. Humans are the only natural hosts of variola. Smallpox is not known to be transmitted by insects or animals.
A person with smallpox is sometimes contagious with onset of fever (prodrome phase), but the person becomes most contagious with the onset of rash. At this stage the infected person is usually very sick and not able to move around in the community. The infected person is contagious until the last smallpox scab falls off.
|Exposure to the virus is followed by an incubation period during which people do not have any symptoms and may feel fine. This incubation period averages about 12 to 14 days but can range from 7 to 17 days. During this time, people are not contagious.|
Initial Symptoms (Prodrome)
|The first symptoms of smallpox include fever, malaise, head and body aches, and sometimes vomiting. The fever is usually high, in the range of 101 to 104 degrees Fahrenheit. At this time, people are usually too sick to carry on their normal activities. This is called the prodrome phase and may last for 2 to 4 days.|
A rash emerges first as small red spots on the tongue and in the mouth.
These spots develop into sores that break open and spread large amounts of the virus into the mouth and throat. At this time, the person becomes most contagious.
Around the time the sores in the mouth break down, a rash appears on the skin, starting on the face and spreading to the arms and legs and then to the hands and feet. Usually the rash spreads to all parts of the body within 24 hours. As the rash appears, the fever usually falls and the person may start to feel better.
By the third day of the rash, the rash becomes raised bumps.
By the fourth day, the bumps fill with a thick, opaque fluid and often have a depression in the center that looks like a bellybutton. (This is a major distinguishing characteristic of smallpox.)
Fever often will rise again at this time and remain high until scabs form over the bumps.
(Duration: about 5 days)
The bumps become pustulessharply raised, usually round and firm to the touch as if there’s a small round object under the skin. People often say the bumps feel like BB pellets embedded in the skin.
|Pustules and Scabs
(Duration: about 5 days)
The pustules begin to form a crust and then scab.
By the end of the second week after the rash appears, most of the sores have scabbed over.
(Duration: about 6 days)
The scabs begin to fall off, leaving marks on the skin that eventually become pitted scars. Most scabs will have fallen off three weeks after the rash appears.
The person is contagious to others until all of the scabs have fallen off.
|Scabs have fallen off. Person is no longer contagious.|
For more about smallpox, see Smallpox Disease.
- Page last reviewed: February 6, 2007
- Page last updated: January 15, 2016
- Content source: CDC Emergency Risk Communication Branch (ERCB), Division of Emergency Operations (DEO), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Get email updates
To receive email updates about this page, enter your email address: